EcoDrugPlus

Glutaminase Kidney Isoform, Mitochondrial-Like

Ensembl ID : ENSOTSG00005042156
Gene Symbol: LOC112253954
3 Cross references
220 Possible Orthologues:

Glutaminase Kidney Isoform, Mitochondrial-Like

Ensembl ID : ENSOTSG00005012993
Gene Symbol: LOC112253780
3 Cross references
220 Possible Orthologues:

Glutaminase Kidney Isoform, Mitochondrial-Like

Ensembl ID : ENSOTSG00005007019
Gene Symbol: LOC112253780
3 Cross references
220 Possible Orthologues:

Glutathione S-Transferase P-Like

Ensembl ID : ENSOTSG00005046241
Gene Symbol: LOC112256363
2 Cross references
147 Possible Orthologues:

Glutathione S-Transferase Pi 1

Ensembl ID : ENSOTSG00005047390
Gene Symbol: GSTP1
1 Cross references
155 Possible Orthologues:

Glutathione S-Transferase Pi 1

Ensembl ID : ENSOTSG00005046238
Gene Symbol: GSTP1
3 Cross references
157 Possible Orthologues:

Glycogen Synthase Kinase 3 Alpha B

Ensembl ID : ENSOTSG00005001227
Gene Symbol: GSK3AB
1 Cross references
181 Possible Orthologues:

Glycogen Synthase Kinase 3 Alpha B

Ensembl ID : ENSOTSG00005002111
Gene Symbol: GSK3AB
1 Cross references
181 Possible Orthologues:

Glycogen Synthase Kinase 3 Beta

Ensembl ID : ENSOTSG00005013424
Gene Symbol: GSK3B
3 Cross references
163 Possible Orthologues:

Glycogen Synthase Kinase-3 Beta-Like

Ensembl ID : ENSOTSG00005034503
Gene Symbol: LOC112262764
2 Cross references
204 Possible Orthologues:

Glycogen Synthase Kinase-3 Beta-Like

Ensembl ID : ENSOTSG00005047101
Gene Symbol: LOC112264807
3 Cross references
180 Possible Orthologues:

Glycogen Synthase Kinase-3 Beta-Like

Ensembl ID : ENSOTSG00005022442
Gene Symbol: LOC112253937
3 Cross references
170 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).